Lilly Supports Cialis Spontaneity With Internet Trial, Direct Patient Data
Executive Summary
Lilly's program to create a "spontaneity" advantage for its erectile dysfunction drug Cialis includes a Phase IIIb trial with direct patient observation reports from an electronic reporting system developed by the California clinical trials firm, 1747, Inc
You may also be interested in...
Pfizer Near Resolution Of GMP Warning Letter; Lilly, Merck Provide Updates
Pfizer expects a re-inspection of its Terre Haute, Ind. injectable manufacturing facility before the end of the month, the company told investors during an April 17 conference call
Pfizer Near Resolution Of GMP Warning Letter; Lilly, Merck Provide Updates
Pfizer expects a re-inspection of its Terre Haute, Ind. injectable manufacturing facility before the end of the month, the company told investors during an April 17 conference call
Lilly/Icos Cialis Marketing Plan Will Target Four Million Former Viagra Users
Marketing efforts for Lilly/Icos' pending erectile dysfunction treatment Cialis will target the approximately four million patients who have discontinued Pfizer's Viagra (sildenafil).